Was Everyone Wrong About Ozempic and Muscle Loss?
Lau Baldo/Unsplash
It’s a GLP-1 world: Critics of GLP-1 medications like Ozempic have warned for years that rapid weight loss comes at a steep cost: loss of muscle and strength. But a new study suggests the conversation may have gotten oversimplified — at least for people with obesity who are medically indicated to take these drugs.
The Study: In a review of four pre-clinical trials and a proof-of-concept clinical trial, researchers analyzed body composition and strength changes in mice and humans with obesity using GLP-1 medications. While participants did lose some lean mass alongside fat mass, the review found that muscle function and strength were generally preserved.
The Takeaway: Losing weight via GLP-1 drugs does not automatically mean losing meaningful muscle function. For people with obesity, these medications may improve health markers while still preserving physical capability, especially when paired with resistance training and adequate protein intake.
Keep in Mind: The pre-clinical trials used mice as subjects. Additionally, the human clinical trial focused on people with obesity, not people taking GLP-1s cosmetically or outside FDA guidelines. Rapid weight loss without strength training or proper nutrition can still increase the risk of muscle loss.
